Will Molecular Dx Shops Benefit If WHO Releases H5N1 Sequences? | GenomeWeb

NEW YORK, March 28 (GenomeWeb News) - Will companies developing molecular diagnostics against the H5N1 flu virus benefit if the World Health Organization makes public the roughly 2,300 viral sequences it maintains for a handful of exclusive labs?

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.